A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Simvastatin in Healthy Volunteers

NCT01821027 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Simvastatin
DRUG: Canagliflozin (JNJ-28431754)

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.